# Injection Free IVF

> **NCT04850261** · PHASE2 · WITHDRAWN · sponsor: **Insel Gruppe AG, University Hospital Bern**

## Conditions studied

- Fertility Disorders

## Interventions

- **DRUG:** hCG Injection
- **DRUG:** Nafarelin nasal spray

## Key facts

- **NCT ID:** NCT04850261
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-05-01
- **Primary completion:** 2024-03-31
- **Final completion:** 2024-03-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The planned study medication was no longer available in Switzerland
- **Last updated:** 2024-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04850261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04850261, "Injection Free IVF". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04850261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*